When was Filament BioSolutions founded?

Filament BioSolutions was founded in 2013 and raised its 1st funding round 3 years after it was founded.

Where is Filament BioSolutions located?

Filament BioSolutions is headquartered in New York City, United States.

Who is the current CEO of Filament BioSolutions?

Tom Cirrito of Filament BioSolutions.

How many employees does Filament BioSolutions have?

As of Jul 31, 2026, the latest employee count at Filament BioSolutions is 1.

Is Filament BioSolutions a funded company?

Filament BioSolutions is a funded company, having raised a total of $***** in its 1st and only funding round, a Series C round on Jan 11, 2016.

When was the latest funding round of Filament BioSolutions?

Filament BioSolutions' latest funding was a $***** Series C round on Jan 11, 2016, with participation from 1 investor. Its primary sector is Nutraceuticals Tech. In United States, the Nutraceuticals Tech sector has seen $160M in funding in 2026 to date.

Where does Filament BioSolutions rank among its competitors?

Filament BioSolutions ranks 6th amongst 32 active competitors, of which 8 are funded. It stands 9th in terms of total funding among its competitors. The most recent competitor to raise funding was Numi, which secured $3.21M in Nov, 2023.

Who are the top competitors of Filament BioSolutions?

Filament BioSolutions' top competitors include Numi, Dr. Schar and Uute Scientific. Among them, Numi secured the most recent funding round in November, 2023.

Filament BioSolutions - 2026 Company Profile, Team, Funding & Competitors

Company Details

Developer of therapeutics and medical foods for a wide range of diseases. The company's lead product is FB-2710 FB-2710, an oral, proprietary formulation of an optimal analog of glutamine, treat Oral Mucositis. The company recently announced a partnership with Ajinomoto to develop a portfolio of evidence-based medical foods and an exclusive license agreement with leading academic institutions for the beverage to prevent kidney stones.

Website: filamentbiosolutions.com
Email ID: *****@filamentbiosolutions.com

Key Metrics

Founded Year

2013

Location

New York City, United States

Stage

Series C

Latest Funding Round

Series C, Jan 11, 2016, $*****

Investors

The Gramercy Fund & 1 more

Ranked

6^th among 32 active competitors

Employee Count

1 as on Jul 31, 2026

Similar Companies

Numi & 69 more

View Filament BioSolutions' full profile

Filament BioSolutions has raised funding over 1 round. Its latest funding round was a Series C round on Jan 11, 2016 for $*****. 1 investor participated in its latest round. Filament BioSolutions has 2 institutional investors.

Here is the list of recent funding rounds of Filament BioSolutions:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Jan 11, 2016	4444931	Series C	1125437	1411663	5192709	1560822

Access funding benchmarks and valuations. Sign up today!

View details of Filament BioSolutions's funding rounds and investors

The founders of Filament BioSolutions are Tom Cirrito and Zeil Rosenberg.

Here are the details of Filament BioSolutions' key team members:

Tom Cirrito: Co-Founder & CEO of Filament BioSolutions and founder of 3 other companies, MedBiome, Biotagenics and Immunovent.
Zeil Rosenberg: Co-Founder of Filament BioSolutions.

View details of Filament BioSolutions's Founder profiles and Board Members

Filament BioSolutions' employee count trend

Filament BioSolutions has 1 employees as of Jul 26. Here is Filament BioSolutions's employee count trend over the years:

Employee count trend for Filament BioSolutions

Uncover Filament BioSolutions' growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Filament BioSolutions include Numi, Dr. Schar and Uute Scientific. Here is the list of Top 10 competitors of Filament BioSolutions, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Numi 2023, Suresnes (France), Seed	Developer of in-vitro breast milk for infants nutrition	$3.21M	Kima Ventures, Heartcore Capital & 3 others	48/100
2nd	Dr. Schar 2003, Burgstall (Italy), Unfunded	Provider of gluten-free nutritional products	-	-	37/100
3rd	Uute Scientific 2019, Helsinki (Finland), Seed	Provider of natural extract products for treating immune-mediated diseases	$1.36M	Butterfly Ventures, Tesi & 1 others	35/100
4th	Tollo Health 2010, New York (United States), Unfunded	Manufacturer of medical foods addressing specific nutritional needs for diseases	-	-	34/100
5th	Ambra Bio 2014, San Diego (United States), Seed	Developer of dietary supplements and medical foods	$1.82M	-	33/100
6th	Filament BioSolutions 2013, New York City (United States), Series C	Developer of therapeutics and medical foods for a wide range of diseases	-	The Gramercy Fund, Ajinomoto	32/100
7th	WellGen 1997, North Brunswick (United States), Series C	Developer of medical foods using nutrigenomics	$12.5M	Amphion Innovations	31/100
8th	Professional Dietetics 1996, Milano (Italy), Unfunded	Developer of medical foods and dietary supplements	-	-	29/100
9th	Targeted Medical Pharma 1999, Los Angeles (United States), Public	Provider of medical foods for multiple disorders	$1.16M	-	27/100
10th	Square Foods 2013, Orinda (United States), Seed	Brand of early-life nutrition products	$1.8M	Target Accelerators	26/100